Logo des Robert Koch-InstitutLogo des Robert Koch-Institut
Publikationsserver des Robert Koch-Institutsedoc
de|en
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
JavaScript is disabled for your browser. Some features of this site may not work without it.
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Gesamter edoc-ServerBereiche & SammlungenTitelAutorSchlagwortDiese SammlungTitelAutorSchlagwort
PublizierenEinloggenRegistrierenHilfe
StatistikNutzungsstatistik
Publikation anzeigen 
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
  • edoc Startseite
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • Publikation anzeigen
2015-03-12Zeitschriftenartikel DOI: 10.25646/1956
Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012
Weiss, Susanne
Falkenhorst, Gerhard
Linden, M. van der
Imöhl, M.
Kries, Rüdiger von
We assessed the impact of 10-valent and 13-valent pneumococcal vaccines (PCV10 and PCV13), which were introduced in Germany in 2009, on the incidence of meningitis and non-meningitis invasive pneumococcal disease (IPD) in children aged under 16 years in a population previously vaccinated with a seven-valent vaccine (PCV7). Surveillance of IPD (isolation of Streptococcus pneumonia from a normally sterile body site) is based on data from two independent reporting sources: hospitals and laboratories. IPD incidence was estimated by capture–recapture analysis. Incidence rate ratios (IRRs) were calculated for 2009 and 2012, thus comparing pre- and post-PCV10 and PCV13 data. IPD incidence caused by serotypes included in PCV13 decreased in all age and diagnosis groups. A rise in non-vaccine serotype incidence was seen only in children aged under two years. The overall impact varied by age group and infection site: for meningitis IPD in children aged under 2, 2–4 and 5–15 years, incidence changed by 3% (95% CI: −31 to 52), −60% (95% CI: −81 to −17) and −9% (95% CI: −46 to 53), respectively. A more pronounced incidence reduction was observed for non-meningitis IPD: −30% (95% CI: −46 to −7), −39% (95% CI: −54 to −20) and −83% (95% CI: −89 to −73) in children aged under 2, 2–4 and 5–15 years, respectively. A higher tropism of the additional serotypes for non-meningitis IPD may be a potential explanation. The heterogeneous findings emphasise the need for rigorous surveillance.
Dateien zu dieser Publikation
Thumbnail
26o7dfbl3VARs.pdf — PDF — 205.5 Kb
MD5: e7624fa35edd8b6c0a7b08bef8416cbe
Zitieren
BibTeX
EndNote
RIS
Keine Lizenzangabe
Zur Langanzeige

Verwandte Publikationen

Anzeige der Publikationen mit ähnlichem Titel, Autor, Urheber und Thema.

  • 2015-07-01Zeitschriftenartikel
    Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany 
    Linden, Mark van der; Falkenhorst, Gerhard; Perniciaro, Stephanie; Imöhl, Matthias
    This study describes the effects of the introduction of universal infant pneumococcal conjugate vaccination in 2006 on invasive pneumococcal disease (IPD) among children and adults in Germany with a focus on the dynamics ...
  • 2021-07-20Zeitschriftenartikel
    The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study 
    Storch, Josephine; Fleischmann‑Struzek, Carolin; Rose, Norman; Lehmann, Thomas; Mikolajetz, Anna; Maddela, Srikanth; Pletz, Mathias W.; Forstner, Christina; Wichmann, Ole; Neufeind, Julia; Vogel, Monique; Reinhart, Konrad; Vollmar, Horst Christian; Freytag, Antje; the Vaccination 60+ Study Group
    Background: To date, cost-effectiveness of influenza and pneumococcal vaccinations was assumed in several health economic modelling studies, but confirmation by real-world data is sparse. The aim of this study is to assess ...
  • 2018-07-16Zeitschriftenartikel
    Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+ 
    Betsch, Cornelia; Rossmann, Constanze; Pletz, Mathias W.; Vollmar, Horst C.; Freytag, Antje; Wichmann, Ole; Hanke, Regina; Hanke, Wolfgang; Heinemeier, Dorothee; Schmid, Philipp; Eitze, Sarah; Weber, Winja; Reinhardt, Anne; Küpke, Nora K.; Forstner, Christina; Fleischmann-Struzek, Carolin; Mikolajetz, Anna; Römhild, Josephine; Neufeind, Julia; Rieck, Thorsten; Suchecka, Kasia; Reinhart, Konrad
    Background: Influenza and pneumococcal vaccination can prevent disease and potentially life-threatening complications like sepsis. Elderly people have an increased risk of severe disease and therefore constitute a major ...
Nutzungsbedingungen Impressum Leitlinien Datenschutzerklärung Kontakt

Das Robert Koch-Institut ist ein Bundesinstitut im

Geschäftsbereich des Bundesministeriums für Gesundheit

© Robert Koch Institut

Alle Rechte vorbehalten, soweit nicht ausdrücklich anders vermerkt.

 
DOI
10.25646/1956
Permanent URL
http://dx.doi.org/10.25646/1956
HTML
<a href="http://dx.doi.org/10.25646/1956">http://dx.doi.org/10.25646/1956</a>